Urologix, Inc. (OTCPK: ULGX)
Health Care · Health Care Equipment & Supplies · US
$0.00
— today · +9900.0% 1Y
Urologix, Inc. (OTCPK: ULGX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.13K and employs 61 people.
Over the last twelve months the share price has gained 9900.0%, trading between 0.00 and 0.03.
Tweenvest scores Urologix, Inc. across four factors: quality 21/100, value 51/100. Its strongest factor is value.
ULGX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.13K
- Revenue (TTM)
- $12.00M
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- -106.66
- 52-week high
- $0.03
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.28M
- Employees
- 61
- Next earnings
- —
About Urologix, Inc.
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia (BPH). Among its key offerings is Cooled ThermoTherapy, a system that precisely applies microwave energy while simultaneously employing a cooling mechanism to safeguard healthy tissues and improve patient comfort. Urologix also provides the Prostiva RF Therapy System, which directs radio frequency energy into the prostate gland. This process works to eliminate problematic prostatic tissue, consequently easing urethral constriction and alleviating BPH-related discomfort. Urologix, Inc. caters to both healthcare professionals and patients.
- ISIN
- US9172731047
- Founded
- 1991
- Listed since
- May 30, 1996
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | 0.00% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.35 | -0.12% |
| Stryker CorporationNYSE: SYK | $126.37B | $330.71 | +0.38% |
| Medtronic plcNYSE: MDT | $119.49B | $93.37 | +0.02% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €161.90 | -0.80% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $49.36 | -2.01% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $191.69 | -0.16% |
Figures last refreshed Aug 18, 2026.